IS8053A - Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra - Google Patents

Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra

Info

Publication number: IS8053A
Authority: IS; Iceland
Prior art keywords: embryos; genes; human carcinoma; represent human; represent
Prior art date: 2003-05-05

Application number

IS8053A

Other languages

English (en)

Inventor

La Monica Nicola

Lahm Armin

Mennuni Carmela

Savino Rocco

Original Assignee

Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-05

Filing date

2005-09-29

Publication date

2005-09-29

2005-09-29 Application filed by Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa filed Critical Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa

2005-09-29 Publication of IS8053A publication Critical patent/IS8053A/is

Links

201000009030 Carcinoma Diseases 0.000 title 1
210000002257 embryonic structure Anatomy 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/70—Enkephalins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IS8053A 2003-05-05 2005-09-29 Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra IS8053A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US46797103P	2003-05-05	2003-05-05
US54361204P	2004-02-11	2004-02-11
PCT/EP2004/004802 WO2004099247A2 (en)	2003-05-05	2004-05-03	Synthetic gene encoding human carcinoembryonic antigen and uses thereof

Publications (1)

Publication Number	Publication Date
IS8053A true IS8053A (is)	2005-09-29

Family

ID=33436748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS8053A IS8053A (is)	2003-05-05	2005-09-29	Tilbúin gen sem tákna mennskt krabbameinsfósturvísa mótefni og notkun þeirra

Country Status (12)

Country	Link
US (1)	US20070104685A1 (is)
EP (1)	EP1622937A2 (is)
JP (1)	JP2007523610A (is)
KR (1)	KR20060003903A (is)
CN (1)	CN1784424A (is)
AU (1)	AU2004235943A1 (is)
CA (1)	CA2523720A1 (is)
IS (1)	IS8053A (is)
NO (1)	NO20055708L (is)
NZ (1)	NZ543922A (is)
RU (1)	RU2005137697A (is)
WO (1)	WO2004099247A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060286114A1 (en) *	2003-08-22	2006-12-21	Luigi Aurisicchio	Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
ATE555127T1 (de) *	2004-02-11	2012-05-15	Angeletti P Ist Richerche Bio	Fusionsproteine des karzinomembryonalen antigens und deren verwendungen
JP4881623B2 (ja)	2006-01-27	2012-02-22	シスメックス株式会社	Ｃｅａ核酸増幅用プライマー、プライマーセット、及びがんの診断支援方法
US20090304725A1 (en) *	2006-02-06	2009-12-10	Medizinische Universitat Wien	Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA
ES2725450T3 (es)	2007-07-02	2019-09-24	Etubics Corp	Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples
NZ582823A (en) *	2007-07-27	2012-04-27	Immatics Biotechnologies Gmbh	Composition of tumour-associated peptides and related anti-cancer vaccine
WO2009117656A2 (en) *	2008-03-21	2009-09-24	Vectorlogics,Inc.	Capsid-incorporated antigen for novel adenovirus vaccine
KR101815322B1 (ko) *	2010-01-12	2018-01-05	서울대학교산학협력단	항암 펩타이드 서열
US9605276B2 (en) *	2012-08-24	2017-03-28	Etubics Corporation	Replication defective adenovirus vector in vaccination
AU2016205215B2 (en)	2015-01-09	2021-03-11	Etubics Corporation	Methods and compositions for combination immunotherapy
US10695417B2 (en)	2015-01-09	2020-06-30	Etubics Corporation	Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
US11149087B2 (en)	2015-04-20	2021-10-19	Etubics Corporation	Methods and compositions for combination immunotherapy
EP3864169A4 (en) *	2018-10-12	2022-07-06	Children's Hospital Medical Center	MODULAR EXPRESSION SYSTEMS FOR GENE EXPRESSION AND METHODS FOR THEIR USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5795737A (en) *	1994-09-19	1998-08-18	The General Hospital Corporation	High level expression of proteins
DE10055545A1 (de) *	2000-11-09	2002-07-25	Deutsches Krebsforsch	Für Expression in Eukaryonten optimierte HPV 16-L1 und HPV 16-L2 kodierende DNA Sequenzen

2004
- 2004-05-03 EP EP04739137A patent/EP1622937A2/en not_active Ceased
- 2004-05-03 WO PCT/EP2004/004802 patent/WO2004099247A2/en not_active Ceased
- 2004-05-03 AU AU2004235943A patent/AU2004235943A1/en not_active Abandoned
- 2004-05-03 CN CNA2004800121157A patent/CN1784424A/zh active Pending
- 2004-05-03 RU RU2005137697/13A patent/RU2005137697A/ru not_active Application Discontinuation
- 2004-05-03 NZ NZ543922A patent/NZ543922A/en unknown
- 2004-05-03 US US10/555,744 patent/US20070104685A1/en not_active Abandoned
- 2004-05-03 CA CA002523720A patent/CA2523720A1/en not_active Abandoned
- 2004-05-03 JP JP2006505382A patent/JP2007523610A/ja not_active Withdrawn
- 2004-05-03 KR KR1020057021059A patent/KR20060003903A/ko not_active Withdrawn
2005
- 2005-09-29 IS IS8053A patent/IS8053A/is unknown
- 2005-12-02 NO NO20055708A patent/NO20055708L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2004235943A1 (en)	2004-11-18
RU2005137697A (ru)	2006-05-10
WO2004099247A2 (en)	2004-11-18
CA2523720A1 (en)	2004-11-18
EP1622937A2 (en)	2006-02-08
CN1784424A (zh)	2006-06-07
US20070104685A1 (en)	2007-05-10
NO20055708D0 (no)	2005-12-02
NZ543922A (en)	2008-05-30
NO20055708L (no)	2006-02-06
KR20060003903A (ko)	2006-01-11
WO2004099247A3 (en)	2005-02-24
JP2007523610A (ja)	2007-08-23

Publication	Publication Date	Title
NO2017017I1 (no)	2017-05-04	umeklinidium og vilanterol
NL350092I2 (nl)	2019-06-04	Combinatie van bixafen en fluoxastrobine
DK1583542T3 (da)	2008-09-22	Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
EP1644729A4 (en)	2010-09-22	ANTI-CD74 immunoconjugates and methods
NO20055837D0 (no)	2005-12-08	Immunsupprimerende forbindelser og sammensetninger
IS8434A (is)	2006-04-27	Verndandi vírnet, verndandi formgerð búin til meðnetinu og notkunin á verndandi vírnetinu við að búa til verndandi formgerð
IS8305A (is)	2006-02-16	Bindandi smíðar og aðferðir við notkun þeirra
DK1644021T3 (da)	2012-10-29	Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1682841T3 (da)	2008-03-31	Flowfordelingsenhed og köleenhed
EE200500035A (et)	2006-02-15	Personaalne teraapiasektsioon
DK1713544T3 (da)	2009-11-16	Sammensætninger og fremgangsmåder til oral og personlig pleje
IS8597A (is)	2007-01-24	Samsetningar rísedrónats og aðferðir við notkun þess
IS7348A (is)	2004-07-08	N-pýrasínýl-fenýlsúlfónamíð og notkun þeirra til að meðhöndla flakkboðatengda sjúkdóma
DE60326145D1 (de)	2009-03-26	Spielermittlungsverfahren
DE60327254D1 (de)	2009-05-28	Den getreideertrag erhöhendes gen und dessen nutzung
DK1771421T3 (da)	2009-07-13	N-hydroxyamidderivater og anvendelse deraf
DE602005020202D1 (de)	2010-05-12	Getrennter Steckverbinder und Verbindereinrichtung
PL2371848T3 (pl)	2018-12-31	Różnie ekspresjonowane w guzach produkty genów i ich zastosowanie
EP1613173A4 (en)	2008-07-09	Fish and the production thereof
IS8489A (is)	2006-05-26	Umritunarstillar og aðferðir þeirra
ATE460415T1 (de)	2010-03-15	Therapeutische pyrazoloä3,4-büpyridine und - indazole
SI1786431T1 (sl)	2016-01-29	Izboljšane formulacije fotosenzibilizatorjev in njihova uporaba
DK1408059T3 (da)	2014-07-28	Latex og fremstilling heraf
NO20055668D0 (no)	2005-11-30	Beta-amyloidinhibitorer og anvendelse derav
GB0321694D0 (en)	2003-10-15	Genes and their therapeutic use